OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma
Mark E. Issa, Farnaz Sedigheh Takhsha, Chandra Sekhar Chirumamilla, et al.
Clinical Epigenetics (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 74
Mark E. Issa, Farnaz Sedigheh Takhsha, Chandra Sekhar Chirumamilla, et al.
Clinical Epigenetics (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 74
Showing 1-25 of 74 citing articles:
The challenge of drug resistance in cancer treatment: a current overview
Michail Nikolaou, Athanasia Pavlopoulou, Alexandros G. Georgakilas, et al.
Clinical & Experimental Metastasis (2018) Vol. 35, Iss. 4, pp. 309-318
Closed Access | Times Cited: 488
Michail Nikolaou, Athanasia Pavlopoulou, Alexandros G. Georgakilas, et al.
Clinical & Experimental Metastasis (2018) Vol. 35, Iss. 4, pp. 309-318
Closed Access | Times Cited: 488
The timeline of epigenetic drug discovery: from reality to dreams
A. Ganesan, Paola B. Arimondo, Marianne G. Rots, et al.
Clinical Epigenetics (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 305
A. Ganesan, Paola B. Arimondo, Marianne G. Rots, et al.
Clinical Epigenetics (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 305
Insights into new mechanisms and models of cancer stem cell multidrug resistance
Yoelsis García-Mayea, Cristina Mir, Frédérick Masson, et al.
Seminars in Cancer Biology (2019) Vol. 60, pp. 166-180
Closed Access | Times Cited: 277
Yoelsis García-Mayea, Cristina Mir, Frédérick Masson, et al.
Seminars in Cancer Biology (2019) Vol. 60, pp. 166-180
Closed Access | Times Cited: 277
The Roles of ROS in Cancer Heterogeneity and Therapy
Paulo Luiz de Sá Júnior, Diana Aparecida Dias Câmara, Allan Saj Porcacchia, et al.
Oxidative Medicine and Cellular Longevity (2017) Vol. 2017, Iss. 1
Open Access | Times Cited: 254
Paulo Luiz de Sá Júnior, Diana Aparecida Dias Câmara, Allan Saj Porcacchia, et al.
Oxidative Medicine and Cellular Longevity (2017) Vol. 2017, Iss. 1
Open Access | Times Cited: 254
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
Christiana M. Neophytou, Ioannis P. Trougakos, Nuray Erin, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4363-4363
Open Access | Times Cited: 244
Christiana M. Neophytou, Ioannis P. Trougakos, Nuray Erin, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4363-4363
Open Access | Times Cited: 244
Epigenetic heterogeneity in cancer
Mingzhou Guo, Yaojun Peng, Aiai Gao, et al.
Biomarker Research (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 233
Mingzhou Guo, Yaojun Peng, Aiai Gao, et al.
Biomarker Research (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 233
Targeting Drug Chemo-Resistance in Cancer Using Natural Products
Wamidh H. Talib, Ahmad R. Alsayed, Muna Barakat, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1353-1353
Open Access | Times Cited: 137
Wamidh H. Talib, Ahmad R. Alsayed, Muna Barakat, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1353-1353
Open Access | Times Cited: 137
Drugging the epigenome in the age of precision medicine
Taylor Feehley, Colm P. O’Donnell, John Mendlein, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 73
Taylor Feehley, Colm P. O’Donnell, John Mendlein, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 73
Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy
Rogério M. Castilho, Cristiane H. Squarize, Luciana O. Almeida
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 7, pp. 1506-1506
Open Access | Times Cited: 152
Rogério M. Castilho, Cristiane H. Squarize, Luciana O. Almeida
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 7, pp. 1506-1506
Open Access | Times Cited: 152
Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress
Маргарита Е. Неганова, С. Г. Клочков, Yulia Aleksandrova, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 452-471
Closed Access | Times Cited: 130
Маргарита Е. Неганова, С. Г. Клочков, Yulia Aleksandrova, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 452-471
Closed Access | Times Cited: 130
Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis
Kazuya Ishiguro, Hiroshi Kitajima, Takeshi Niinuma, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 59
Kazuya Ishiguro, Hiroshi Kitajima, Takeshi Niinuma, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 59
Cancer Stem Cells: Powerful Targets to Improve Current Anticancer Therapeutics
Rayana Longo Bighetti‐Trevisan, Lucas Oliveira Sousa, Rogério M. Castilho, et al.
Stem Cells International (2019) Vol. 2019, pp. 1-15
Open Access | Times Cited: 57
Rayana Longo Bighetti‐Trevisan, Lucas Oliveira Sousa, Rogério M. Castilho, et al.
Stem Cells International (2019) Vol. 2019, pp. 1-15
Open Access | Times Cited: 57
Targeting the epigenome in in-stent restenosis: from mechanisms to therapy
Xi Yang, Yanyan Yang, Junjie Guo, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 23, pp. 1136-1160
Open Access | Times Cited: 54
Xi Yang, Yanyan Yang, Junjie Guo, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 23, pp. 1136-1160
Open Access | Times Cited: 54
Multiple Myeloma: Challenges Encountered and Future Options for Better Treatment
Srijit Das, Norsham Juliana, Noor Anisah Abu Yazit, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1649-1649
Open Access | Times Cited: 34
Srijit Das, Norsham Juliana, Noor Anisah Abu Yazit, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1649-1649
Open Access | Times Cited: 34
Role of epigenetics-microRNA axis in drug resistance of multiple myeloma
Nasrin Rastgoo, Jahangir Abdi, Jian Hou, et al.
Journal of Hematology & Oncology (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 58
Nasrin Rastgoo, Jahangir Abdi, Jian Hou, et al.
Journal of Hematology & Oncology (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 58
The future of myeloma precision medicine: integrating the compendium of known drug resistance mechanisms with emerging tumor profiling technologies
Taylor Harding, Linda B. Baughn, Shaji Kumar, et al.
Leukemia (2019) Vol. 33, Iss. 4, pp. 863-883
Closed Access | Times Cited: 52
Taylor Harding, Linda B. Baughn, Shaji Kumar, et al.
Leukemia (2019) Vol. 33, Iss. 4, pp. 863-883
Closed Access | Times Cited: 52
The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response
Eva De Smedt, Hui Lui, Ken Maes, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 47
Eva De Smedt, Hui Lui, Ken Maes, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 47
The p38/MKP-1 signaling axis in oral cancer: Impact of tumor-associated macrophages
Zhenning Li, Fayu Liu, Keith L. Kirkwood
Oral Oncology (2020) Vol. 103, pp. 104591-104591
Open Access | Times Cited: 45
Zhenning Li, Fayu Liu, Keith L. Kirkwood
Oral Oncology (2020) Vol. 103, pp. 104591-104591
Open Access | Times Cited: 45
Fucoidan-coated coral-like Pt nanoparticles for computed tomography-guided highly enhanced synergistic anticancer effect against drug-resistant breast cancer cells
Seounghun Kang, Kyunglee Kang, Ari Chae, et al.
Nanoscale (2019) Vol. 11, Iss. 32, pp. 15173-15183
Closed Access | Times Cited: 44
Seounghun Kang, Kyunglee Kang, Ari Chae, et al.
Nanoscale (2019) Vol. 11, Iss. 32, pp. 15173-15183
Closed Access | Times Cited: 44
Epigenetic regulation in the pathogenesis of non-melanoma skin cancer
Mahendra Kashyap, Rajesh Sinha, M. Shahid Mukhtar, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 36-56
Closed Access | Times Cited: 42
Mahendra Kashyap, Rajesh Sinha, M. Shahid Mukhtar, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 36-56
Closed Access | Times Cited: 42
Ferroptosis Induction in Multiple Myeloma Cells Triggers DNA Methylation and Histone Modification Changes Associated with Cellular Senescence
Emilie Logie, Bart Van Puyvelde, Bart Cuypers, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12234-12234
Open Access | Times Cited: 40
Emilie Logie, Bart Van Puyvelde, Bart Cuypers, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12234-12234
Open Access | Times Cited: 40
Multiple Myeloma and Bone: The Fatal Interaction
Silvia Marino, G. David Roodman
Cold Spring Harbor Perspectives in Medicine (2017) Vol. 8, Iss. 8, pp. a031286-a031286
Open Access | Times Cited: 44
Silvia Marino, G. David Roodman
Cold Spring Harbor Perspectives in Medicine (2017) Vol. 8, Iss. 8, pp. a031286-a031286
Open Access | Times Cited: 44
The effect of sodium butyrate and cisplatin on expression of EMT markers
Alena Mrkvicová, Marcela Chmelařová, Eva Peterová, et al.
PLoS ONE (2019) Vol. 14, Iss. 1, pp. e0210889-e0210889
Open Access | Times Cited: 39
Alena Mrkvicová, Marcela Chmelařová, Eva Peterová, et al.
PLoS ONE (2019) Vol. 14, Iss. 1, pp. e0210889-e0210889
Open Access | Times Cited: 39
Aggresome formation promotes ASK1/JNK signaling activation and stemness maintenance in ovarian cancer
Yurou Chen, Yulong Qiang, Jiachen Fan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Yurou Chen, Yulong Qiang, Jiachen Fan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Aberrant DNA Methylation of ABC Transporters in Cancer
Katja Zappe, Margit Cichna‐Markl
Cells (2020) Vol. 9, Iss. 10, pp. 2281-2281
Open Access | Times Cited: 30
Katja Zappe, Margit Cichna‐Markl
Cells (2020) Vol. 9, Iss. 10, pp. 2281-2281
Open Access | Times Cited: 30
